Patents Assigned to Research
-
Publication number: 20200153106Abstract: An integrated horn antenna with an integral polarization converter, and a method of manufacturing the integrated horn antenna are disclosed. The integrated horn antenna includes a horn, and a polarizer of which at least a portion is disposed in an internal space defined by an inner wall of the horn.Type: ApplicationFiled: August 16, 2019Publication date: May 14, 2020Applicant: Electronics and Telecommunications Research InstituteInventors: So-hyeun YUN, Changsoo KWAK, Man Seok UHM, Hongyeol LEE, Dong Pil CHANG
-
Publication number: 20200148914Abstract: A method of forming a thermal insulation porous film includes mixing 100 parts by weight of polysilsesquioxane-containing polymer, 20 to 75 parts by weight of surfactant, and 20 to 2000 parts by weight of solvent to form a thermal insulation coating material, wherein the polysilsesquioxane-containing polymer in the thermal insulation coating material is tube-shaped or sheet-shaped. The thermal insulation coating material is coated on a substrate, and then dried and sintered to form a thermal insulation porous film.Type: ApplicationFiled: January 15, 2020Publication date: May 14, 2020Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTEInventors: Yuan-Chang HUANG, Yi-Che SU, Shu-Yun CHIEN, Hong-Yuan LIAN, Huai-Kuang FU, Pang-Hung LIU
-
Patent number: 10646570Abstract: Photodynamic therapy systems comprising a nanoparticle that emits electromagnetic radiation having a first wavelength when irradiated with electromagnetic radiation, a photosensitizer which absorbs electromagnetic radiation of said first wavelength and a biocompatible mesoporous material are disclosed herein. In some examples, the photodynamic therapy system comprises a core comprising the nanoparticle, a first shell comprising the biocompatible mesoporous material, and a photosensitizer embedded in the first shell. Upon irradiation by, for example, X-rays, the nanoparticle can function as a transducer, converting X-ray photons to visible photons, and in turn, activating the photosensitizers. Methods of using the photodynamic therapy system are also disclosed.Type: GrantFiled: June 18, 2015Date of Patent: May 12, 2020Assignee: UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC.Inventors: Jin Xie, Hongmin Chen, Geoffrey D. Wang
-
Patent number: 10647827Abstract: Provided are an engineering plastic composite and a method for producing the same. The engineering plastic composite includes a carbon fiber having a surface modified by a hydrogen plasma and including a functional group and an engineering plastic. The carbon fiber is mixed with the engineering plastic to constitute a composite.Type: GrantFiled: February 3, 2017Date of Patent: May 12, 2020Assignee: Korea University Research and Business FoundationInventors: Dae-Soon Lim, Eung-seok Lee, Choonghyun Lee
-
Patent number: 10648729Abstract: There is provided a system and method for producing liquefied natural gas (LNG). An exemplary method includes flowing a high-pressure stream of LNG through a first series of liquid turbines. The exemplary method also includes generating electricity by reducing the pressure of the high-pressure stream of LNG to form a low-pressure stream of LNG. The exemplary method additionally includes bypassing any one the liquid turbines that has a failure while continuing to produce electricity from the first series.Type: GrantFiled: September 15, 2016Date of Patent: May 12, 2020Assignee: ExxonMobil Upstream Research CompanyInventors: Christopher G. Holt, Todd S. Griffith
-
Patent number: 10651080Abstract: Thin AlN films are oxidatively treated in a plasma to form AlO and AlON films without causing damage to underlying layers of a partially fabricated semiconductor device (e.g., to underlying metal and/or dielectric layers). The resulting AlO and AlON films are characterized by improved leakage current compared to the AlN film and are suitable for use as etch stop layers. The oxidative treatment involves contacting the substrate having an exposed AlN layer with a plasma formed in a process gas comprising an oxygen-containing gas and a hydrogen-containing gas. In some implementations oxidative treatment is performed with a plasma formed in a process gas including CO2 as an oxygen-containing gas, H2 as a hydrogen-containing gas, and further including a diluent gas. The use of a hydrogen-containing gas in the plasma eliminates the oxidative damage to the underlying layers.Type: GrantFiled: June 28, 2016Date of Patent: May 12, 2020Assignee: Lam Research CorporationInventors: Meliha Gozde Rainville, Nagraj Shankar, Daniel Damjanovic, Kapu Sirish Reddy
-
Patent number: 10651092Abstract: Semiconductor device and fabrication method are provided. The method includes: providing a base substrate; forming an isolation structure film on the base substrate, a top portion of the isolation structure film containing a plurality of first openings; forming a second opening at a bottom of each first opening by removing a portion of the isolation structure film to expose a surface of the base substrate, where the second opening has a size larger than a corresponding first opening along a direction in parallel with the surface of the base substrate; forming fins in the first and second openings; and forming an isolation structure by removing a portion of an isolation material film, where a top surface of the isolation structure is lower than a top surface of the fins and the isolation structure covers a portion of the sidewalls of the fins. The semiconductor devices formed by the method may reduce the self-heating effect and improve the performance of semiconductor devices.Type: GrantFiled: December 27, 2018Date of Patent: May 12, 2020Assignees: Semiconductor Manufacturing International (Shanghai) Corporation, SMIC New Technology Research and Development (Shanghai) CorporationInventor: Fei Zhou
-
Patent number: 10646389Abstract: Person support apparatuses with selectively coupled foot sections are disclosed. In one embodiment, the person support apparatus includes a base frame, a primary support frame supported on the base frame, and a foot section coupled to the primary support frame. The person support apparatus also includes a carriage that is freely translatable between a head end of the primary support frame and a foot end of the primary support frame, the carriage comprising a torso portion and a seat portion having a thigh segment and a gluteal segment. The person support apparatus further includes a selectable trunnion that selectively and severally couples the foot section to the primary support frame and the thigh segment of the seat portion.Type: GrantFiled: April 17, 2015Date of Patent: May 12, 2020Assignee: Liko Research & Development ABInventors: Thomas F. Heil, Glenn C. Suttman
-
Patent number: 10647748Abstract: The present invention provides HIV-1 vaccine immunogens. Some of the immunogens contain a soluble gp140-derived protein that harbors a modified N-terminus of the HR1 region in gp41. Some of the immunogens contain an HIV-1 Env-derived trimer protein that is presented on a nanoparticle platform. The invention also provides methods of using the HIV-1 vaccine immunogens for eliciting an immune response or treating HIV infections.Type: GrantFiled: October 31, 2018Date of Patent: May 12, 2020Assignee: The Scripps Research InstituteInventors: Leopold Kong, Ian A. Wilson, Natalia De Val, Andrew B. Ward, Dennis Burton, Linling He, Jiang Zhu
-
Patent number: 10651680Abstract: An uninterruptible power supply apparatus and method. The uninterruptible power supply apparatus includes a first generator, an energy storage, a first power converter connected to the energy storage, a second power converter connected to the energy storage, a first switch connected to the first power converter and a first load, a second switch connected to the second power converter, the first generator and a second load, and a third switch connected to a power grid, the first generator, the second power converter, the first switch and the second switch. In a normal state in which the first switch and the third switch are connected, the power grid supplies power to the first load or the second load. In an independent operating state in which the third switch is turned off, the first generator or the energy storage uninterruptibly supplies power to the first load or the second load.Type: GrantFiled: June 28, 2018Date of Patent: May 12, 2020Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTEInventors: Sewan Heo, Wan Ki Park, Jinsoo Han
-
Patent number: 10648978Abstract: Identification of autoantibodies associated with Crohn's disease useful in diagnosis and management using an innovative protein array technology, namely nucleic acid programmable protein arrays (NAPPA) and applications relating thereto. Overall, reactivity of IgG autoantibodies was stronger than that of IgA autoantibodies; however, IgA autoantibodies showed greater differential reactivity between cases and controls. Four IgA autoantibodies against SNRPB, PRPH, PTTG1 and SNAI1 were newly identified with sensitivities above 15% at 95% specificity, among which anti-SNRPB-IgA had the highest sensitivity of 24.0%. Autoantibodies associated with specific disease subtypes were also found.Type: GrantFiled: February 9, 2018Date of Patent: May 12, 2020Assignees: Mayo Foundation for Medical Education and Research, Arizona Board of Regents on behalf of Arizona State UniversityInventors: Haoyu Wang, Ji Qiu, Joshua LaBaer, Jonathan Leighton, Shabana Pasha
-
Patent number: 10646129Abstract: Methods and an apparatus are provided, which may be used for determining the prognosis and/or diagnosis of a subject demonstrating burst suppression, whereby the subject has or is at risk of developing brain damage. In particular, the methods and apparatus determine the prognosis and/or diagnosis through the detection of bursts from a reading of electrical and/or electromagnetic activity of the subject's brain, such as an electroencephalogram (EEG), and subsequent analysis of one or more burst metrics derived therefrom.Type: GrantFiled: November 20, 2014Date of Patent: May 12, 2020Assignee: THE COUNCIL OF THE QUEENSLAND INSTITUTE OF MEDICAL RESEARCHInventors: Michael Breakspear, James Roberts, Sampsa Vanhatalo
-
Patent number: 10649243Abstract: An article includes a substrate with at least first and second materials disposed in or over the substrate. The first material is a non-color changeable material of at least one first color and the second material is a thermochromic color changeable material activated to produce at least one second color different from the first color. Additive color mixing of the first and second colors produces at least one third color different from the first and second colors.Type: GrantFiled: July 30, 2018Date of Patent: May 12, 2020Assignee: Palo Alto Research Center IncorporatedInventors: Warren B. Jackson, Christopher L. Chua, Ashish Pattekar
-
Patent number: 10648079Abstract: A process chamber for depositing a film on a wafer is provided, including: a pedestal having, a central top surface having a plurality of wafer supports configured to support the wafer at a support level above the central top surface, an annular surface at a step down from the central top surface; a carrier ring configured to be supported by carrier ring supports such that a bottom surface of the carrier ring is at a first vertical separation above the annular surface, the carrier ring having a step down surface defined relative to a top surface; wherein when the carrier ring is seated on the carrier ring supports, then the step down surface of the carrier ring is positioned at a process level that is at a second vertical separation from the support level over the top surface of the pedestal.Type: GrantFiled: December 19, 2014Date of Patent: May 12, 2020Assignee: Lam Research CorporationInventors: Chloe Baldasseroni, Andrew Duvall, Ryan Blaquiere, Shankar Swaminathan
-
Patent number: 10648005Abstract: The present disclosure relates to the transformed Synechococcus elongatus strain of capable of mass production of farnesene. The transformed Synechococcus elongatus strain of the present disclosure is characterized by having the ability to mass produce farnesene using carbon dioxide as an independent carbon source. In particular, the Synechococcus elongatus strain is economically effective because it uses carbon dioxide present in light and air as a carbon source. There is an eco-friendly effect since it can be used for eliminating or reducing carbon dioxide in the atmosphere using microorganisms. Further, the strain of the present disclosure has a rapid growth rate and excellent ability to fix carbon dioxide compared with other microorganisms, thereby being utilized in various fields such as food, medicine, pharmacy, biofuel, and chemistry.Type: GrantFiled: October 2, 2018Date of Patent: May 12, 2020Assignee: Research & Business Foundation Sungkyunkwan UniversityInventors: Han-Min Woo, Hyun-Jeong Lee
-
Patent number: 10646548Abstract: The present invention is directed to compositions including the cytokines IL-18 and IL-22 or biologically active fragments or variants thereof. In some embodiments, the compositions further include a pharmaceutically acceptable carrier. The compositions can further include other interleukins such as IL-1?, and IL 1? can be used as a combination therapy with either IL-18 or IL-22 or biologically active fragments or variants thereof.Type: GrantFiled: October 8, 2014Date of Patent: May 12, 2020Assignee: Georgia State University Research Foundation, Inc.Inventors: Andrew T. Gewirtz, Benyue Zhang
-
Patent number: 10648387Abstract: An exhaust gas post processing apparatus of a gasoline vehicle may include a housing mounted on the exhaust pipe to receive the exhaust gas discharged from the engine and to exhaust the exhaust gas passed through rearward thereof, a front end honeycomb catalyst unit embedded in the housing to primarily purify the exhaust gas introduced into the housing through a front end portion of the housing, and a rear end honeycomb catalyst unit embedded in the housing to secondarily purify the exhaust gas via the front end honeycomb catalyst unit before flowing out to a rear end portion of the housing, wherein the front end honeycomb catalyst unit includes a powder type catalyst in which an iridium-ruthenium alloy is supported on an aluminum oxide support powder, and the rear end honeycomb catalyst unit includes three-way catalyst powder which is configured to remove carbon monoxide, nitrogen oxides, and hydrocarbons simultaneously.Type: GrantFiled: November 25, 2019Date of Patent: May 12, 2020Assignees: Hyundai Motor Company, Kia Motors Corporation, Korea Research Institute of Chemical TechnologyInventors: Dalyoung Yoon, Chang Hwan Kim, Iljeong Heo, Young Woo You, Jin Hee Lee
-
Patent number: 10647737Abstract: A synthetic charged glycolipid is described comprising a sulfated saccharide group covalently linked to the tree sn-1 hydroxyl group of the glycerol backbone of an archaeal core lipid via a beta linkage. The synthetic charged glycolipids include compounds of formula I wherein n is 0 or 1; R is hydrogen or hydroxyl; and Y is hydrogen or a sulfate group, at least one Y being a sulfate group; and including pharmaceutically acceptable salts thereof. The sulfated glycolipid produces stable archaeosomes at a mol % ratio of from 100:0 to 30:70 (sulfated glycolipid:uncharged glycolipid) and which induce a protective immune response, including CD8+ and CD4+ T cell responses. Archaeosomes comprising the sulfated glycolipids described have desirable adjuvant properties, particularly when mixed with uncharged glycolipid at a mol % ratio of about 50:50.Type: GrantFiled: July 10, 2015Date of Patent: May 12, 2020Assignee: National Research Council of CanadaInventors: Dennis M. Whitfield, G. Dennis Sprott, Lakshmi Krishnan
-
Patent number: 10648011Abstract: The present invention provides members that produce on a large scale a coenzyme-linked glucose dehydrogenase which has excellent substrate-recognizing ability toward glucose while providing low action on maltose. The present invention relates to a polynucleotide encoding a soluble coenzyme-linked glucose dehydrogenase that catalyzes the oxidation of glucose in the presence of an electron acceptor and has an activity toward maltose of 5% or lower; a polypeptide encoded by the nucleotide sequence of the polynucleotide; a recombinant vector carrying the polynucleotide; a transformed cell produced using the recombinant vector; a method for producing a polypeptide comprising culturing the transformed cell and collecting from the cultivated products a polypeptide that links to FAD to exert the glucose dehydration activity; a method for determination of glucose using the polypeptide; a reagent composition for determination of glucose; and a biosensor.Type: GrantFiled: March 21, 2018Date of Patent: May 12, 2020Assignees: Ikeda Food Research Co., ltd., PHC CorporationInventors: Hironori Omura, Hirokazu Sanada, Takako Yada, Ayaka Atsumi, Tetsunari Morita, Emi Ishimaru
-
Patent number: 10649139Abstract: An optical waveguide structure includes a substrate and a core structure disposed on the substrate. The substrate includes a first waveguide region, a second waveguide region, and a transition region between the first waveguide region and the second waveguide region. The core structure includes first core segments arranged in a first direction and a second direction crossing the first direction on the transition region. The core structure includes second core segments arranged in the first direction and the second direction on the second waveguide region. The first direction and the second direction are parallel to a top surface of the substrate.Type: GrantFiled: December 10, 2018Date of Patent: May 12, 2020Assignee: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTEInventors: Duk Jun Kim, Young-Ho Ko, Dong-Young Kim, Jong-Hoi Kim, Yongsoon Baek, Jung-Ho Song, Dong Hyo Lee, Byung-Seok Choi, Won Seok Han